Iguratimod ≥98.0% (by HPLC, titration analysis)
Supplier: TCI America
|
Warning
|
Synonyms:
N-[7-(Methanesulfonamido)-4-oxo-6-phenoxy-4H-chromen-3-yl]formamide, N-(3-Formamido-4-oxo-6-phenoxy-4H-chromen-7-yl)methanesulphonamide, N-(3-Formamido-4-oxo-6-phenoxy-4H-chromen-7-yl)methanesulfonamide, N-[7-(Methanesulphonamido)-4-oxo-6-phenoxy-4H-chromen-3-yl]formamide, N-(7-(Methylsulfonamido)-4-oxo-6-phenoxy-4H-chromen-3-yl)formamide, N-(7-(Methylsulphonamido)-4-oxo-6-phenoxy-4H-chromen-3-yl)formamide
I0945-250MG
I0945-25MG
TCI0945-250MGEA
478.74
CAD
TCI0945-250MG
TCI0945-25MG
Iguratimod ≥98.0% (by HPLC, titration analysis)
Iguratimod
Formula:
C₁₇H₁₄N₂O₆S MW: 374.37 g/mol |
MDL Number:
MFCD00882374 CAS Number: 123663-49-0 |
Specification Test Results
Appearance | White to Almost white powder to crystal |
Purity (HPLC) | min. 98.0 area% |
Purity (Neutralization titration) | min. 98.0 % |
Melting point | 238.0 to 242.0 deg-C |
Learn more

About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...